MedPath

Efficacy of topical formulation of Henna in itching sensation and wound healing in patients with epidermolysis bullosa

Phase 2
Conditions
Epidermolysis Bullosa Dystrophica.
Epidermolysis bullosa dystrophica
Q81.2
Registration Number
IRCT20150825023753N14
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
7
Inclusion Criteria

Patients with Epidermolysis Bullosa
Age over 5 years old
Patient or his/her parent's consent to participate in the study

Exclusion Criteria

Patients younger than 5 years old
Patients or their parents not consenting to participate in the study
Positive history of allergic to Henna
Patients with G6PD deficiency (Glucose-6-phosphate dehydrogenase deficiency)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Itching score. Timepoint: Once a week until 1 month. Method of measurement: Visual Analogue Scale (VAS).;Percentage of wound healing. Timepoint: Percentage of wound healing. Method of measurement: Clinical global impression of improvement.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath